Detalhe da pesquisa
1.
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
J Cutan Med Surg
; 27(6): 594-600, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37571829
2.
Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis.
J Am Acad Dermatol
; 84(1): 60-69, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798580
3.
Evaluation of Risk of Major Adverse Cardiovascular Events with Biologic Therapy in Patients with Psoriasis (Errata).
J Drugs Dermatol
; 19(6): 566-570, 2020 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32574027
4.
Safety surveillance for ustekinumab and other psoriasis treatments from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Errata.
J Drugs Dermatol
; 19(6): 571-572, 2020 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32574028
5.
Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies Errata.
J Drugs Dermatol
; 19(6): 573-574, 2020 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32574029
6.
Non-Melanoma Skin Cancer Risk Among Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
J Drugs Dermatol
; 18(10): 1059-1060, 2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31603636
7.
Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report.
Am J Gastroenterol
; 113(11): 1678-1688, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30022113
8.
Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).
J Am Acad Dermatol
; 78(1): 70-80, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29102053
9.
Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry.
J Am Acad Dermatol
; 77(5): 845-854.e5, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28893407
10.
Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
J Drugs Dermatol
; 16(10): 1002-1013, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29036254
11.
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).
J Am Acad Dermatol
; 74(5): 851-61.e4, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26853180
12.
WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).
J Am Acad Dermatol
; 2015 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25582533
13.
Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
J Drugs Dermatol
; 14(7): 706-14, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26151787
14.
Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.
Am J Gastroenterol
; 109(2): 212-23, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24394749
15.
Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): experience with infliximab and other systemic and biologic therapies.
J Drugs Dermatol
; 13(12): 1441-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25607786
16.
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study.
BMC Rheumatol
; 8(1): 20, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773563
17.
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study.
Rheumatol Ther
; 10(3): 659-678, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820983
18.
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study.
BMC Rheumatol
; 7(1): 5, 2023 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36973741
19.
Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.
Am J Gastroenterol
; 107(9): 1409-22, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22890223
20.
Machine Learning Applied to Patient-Reported Outcomes to Classify Physician-Derived Measures of Rheumatoid Arthritis Disease Activity.
ACR Open Rheumatol
; 4(12): 995-1003, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220128